Sciomics offers multiplex protein analysis services for protein expression profiling, combined phosphorylation and protein analysis, drug target and biomarker discovery as well as custom antibody microarray production.
Our protein as well as phosphorylation analyses are covering 1.030 different highly relevant proteins. This is currently the world’s most comprehensive commercially available immuno-based platform for a multiplexed protein and phosphorylation analysis. The microarray based analysis is robust (CV < 10%), cost-efficient and only minute amounts of precious samples (e.g. 10µL plasma) are required.
Our complete sample-to-result service covers
• study design consultation
• protein extraction
• microarray experiments
• data analysis adapted to your individual needs
• a study report presented in a publication ready format
Sciomics’ customers are from academic research institutes and contract research organizations as well as from the diagnostic and pharmaceutical industry.
scioDiscover: Protein Expression Profiling
Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised range of protein profiling services available. These help you to speed up your research and generate important data at lower cost through a highly-parallel protein expression level analysis using our Scio-Discover Antibody Microarray Platform. Furthermore, you may link to and verify your Genomics and Transcriptomics data with protein expression levels.
scioDiscover - Protein Biomarker Discovery
Personalised Medicine and Diagnostic Research require techniques to discover and verify novel and more accurate Biomarkers. We offer a comprehensive immuno-based Protein Biomarker Discovery Service using complex Antibody Microarrays. This platform covers key pathway proteins for various diseases as well as secreted proteins and was successfully applied in a variety of biomedical studies. The potential of our platform is underlined by the successful discovery of 4 innovative biomarker signatures.
Due to the fully immuno-based workflow a major platform change is not required for further development and therefore can decrease attrition rates of biomarker candidates. With more than 10 years of experience Sciomics is the ideal partner for Protein Biomarker Discovery and Verification.
Biomarker Discovery for:
scioPhospho: Protein & Phosphorylation Analysis
scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway activity regulation.
Sciomics GmbH has not received any reviews.
Sciomics GmbH has not received any endorsements.